UPClytics
View all cases

UPC APP 7184/2024

·EP3646825: A SYSTEM COMPRISING A PROSTHETIC VALVE AND A DELIVERY CATHETER

Case details
Status
Action
Procedural application
Category
Other Procedural
Parties
Claimants
Reps: Emmanuel Larere (Cabinet Gide Loyrette Nouel AARPI); Raphaëlle Dequiré-Portier (Cabinet Gide Loyrette Nouel AARPI)
Respondents
Reps: Boris Kreye (Bird & Bird LLP); Siddharth Kusumakar (Powell Gilbert (Europe) LLP); Tessa Waldron (Powell Gilbert (Europe) LLP)
Division
Paris CD
Judges
Technology
Pharmaceutical & Medical
Language
First decided
Feb 27, 2024
Last decision
Feb 28, 2024
Decisions
  • 2024-02-28
    Generic application

    The Paris Central Division issued a procedural order in a revocation action concerning EP3646825 (Edwards Lifesciences v Meril Italy), addressing a request by Meril to allow a subsequent amendment to the patent by Edwards, in the context of compliance with R.30 RoP requirements for patent amendment applications.

    Legal issues:Subsequent amendment to patent application (R.30 RoP)Admissibility of request to amend patentAmendment of case (R.263 RoP)
  • 2024-02-27
    Generic application

    The Paris Central Division ruled on Meril Italy's application to refuse admission of Edwards Lifesciences' subsequent request to amend patent EP 3 646 825, addressing the admissibility of post-deadline patent amendment requests under R.30(2) RoP.

    Legal issues:admissibility of subsequent patent amendment request R.30(2) RoPleave to amend case R.263 RoP
  • 2024-02-27
    Generic application

    The Paris Central Division ruled on Meril Italy's application to refuse admission of Edwards Lifesciences' subsequent request to amend patent EP 3 646 825, addressing the admissibility of post-deadline patent amendment requests under R.30(2) RoP.

    Legal issues:admissibility of subsequent patent amendment request R.30(2) RoPleave to amend case R.263 RoP
Documents
  • 2024-02-27%20CD%20Paris%20UPC_CFI_255-2023%20ORD_7283-2024%20App_7184-2024%20anonymized%20%281%29.pdf2024-02-27EN
  • 2024-02-27%20CD%20Paris%20UPC_CFI_255-2023%20ORD_7283-2024%20App_7184-2024%20anonymized.pdf2024-02-27EN
  • 3E509F6CA88E0F9BF9D2C0021F547EAE_en.pdf2024-02-28EN
Meril Italy S.r.l. v Edwards Lifesciences Corporation — UPC APP 7184/2024 | UPClytics